Efficacy and safety of direct antiviral agents in a cohort of cirrhotic HCV/HIV-coinfected patients-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Efficacy and safety of direct antiviral agents in a cohort of cirrhotic HCV/HIV-coinfected patients

Published:2017-07-13 Issue:10 Volume:72 Page:2850-2856
ISSN:0305-7453
Container-title:Journal of Antimicrobial Chemotherapy
language:en
Short-container-title:

Author:

Navarro Jordi¹²,Laguno Montserrat³,Vilchez Helem Haydee⁴,Guardiola Jose M⁵,Carrion Jose A⁶,Force Luis⁷,Cairó Mireia⁸,Cifuentes Carmen⁹,Vilaró Josep¹⁰,Cucurull Josep¹¹,Marco Andrés¹²,Roget Mercè¹³,Erice Eva¹⁴,Crespo Manuel¹⁵,Crespo Manuel,Roget Mercè,Ortiz Jordi,Aparicio Carla,Laguno Montserrat,Mallolas Josep,Rebollar Maria Martínez,Cucurull Josep,Carrión Jose Antonio,Puigvehí Marc,Force Luis,Barrufet Pilar,Sempere Gloria,Erice Eva,Guardiola Josep M,Cairó Mireia,Vilchez Helem Haydee,Cifuentes Carmen,Navarro Jordi,Pérez Mercè,Vilaró Josep,Marco Andrés,Sarriera Carmen,Valls Imma, ,

Affiliation:

1. Hospital Universitari de la Vall d’Hebron, Universitat Autònoma de Barcelona, Barcelona, España

2. Institut de Recerca Hospital Vall d’Hebron, Barcelona, España

3. Hospital Clínic de Barcelona, Barcelona, España

4. Hospital Universitari de Son Espases, Palma de Mallorca, España

5. Hospital de la Santa Creu i Sant Pau, Barcelona, España

6. Hospital del Mar, Institut Hospital del Mar d’Investigacions Mèdiques (IMIM), Universitat Autònoma de Barcelona (UAB), Barcelona, España

7. Hospital de Mataró, Mataró, España

8. Hospital Universitari Mútua de Terrassa, Terrassa, España

9. Hospital de Son Llàtzer, Palma de Mallorca, España

10. Hospital Universitari de Vic, Vic, España

11. Hospital de Figueres, Figueres, España

12. Programa Penitenciari, Institut Català de la Salut, Barcelona, España

13. Consorci Sanitari de Terrassa, Terrassa, España

14. Fundació privada Hospital de Mollet, Mollet del Vallès, España

15. Complexo Hospitalario Universitario de Vigo, IIS Galicia Sur, España

Funder

Instituto de Salud Carlos III

ISCIII

FEDER

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Pharmacology (medical),Pharmacology,Microbiology (medical)

Link

http://academic.oup.com/jac/article-pdf/72/10/2850/21587564/dkx223.pdf

Reference31 articles.

1. Simeprevir with pegylated interferon alfa 2a plus ribavirin in treatment-naive patients with chronic hepatitis C virus genotype 1 infection (QUEST-1): a phase 3, randomised, double-blind, placebo-controlled trial;Jacobson;Lancet,2014

2. Sofosbuvir for previously untreated chronic hepatitis C infection;Lawitz;N Engl J Med,2013

3. Ledipasvir and sofosbuvir for HCV in patients coinfected with HIV-1;Naggie;N Engl J Med,2015

4. Ombitasvir, paritaprevir co-dosed with ritonavir, dasabuvir, and ribavirin for hepatitis C in patients co-infected with HIV-1: a randomized trial;Sulkowski;JAMA,2015

5. Daclatasvir plus sofosbuvir for HCV in patients coinfected with HIV-1;Wyles;N Engl J Med,2015

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Safety and tolerability of OP-724 in patients with haemophilia and liver cirrhosis due to HIV/HCV coinfection: an investigator-initiated, open-label, non-randomised, single-centre, phase I study;BMJ Open Gastroenterology;2024-04

2. Sex‐related difference analyses of efficacy and safety in clinical trials of direct‐acting antivirals to treat chronic HCV genotype 1 and 3 infections;Journal of Viral Hepatitis;2023-12-19

3. Pangenotypic and Genotype-Specific Antivirals in the Treatment of HCV Genotype 4 Infected Patients with HCV Monoinfection and HIV/HCV Coinfection;Journal of Clinical Medicine;2022-01-13

4. Long term immunological perturbations post DAA therapy in chronic HCV/HIV co-infected patients;BIOCELL;2022

5. Association of Sofosbuvir and Daclatasvir Plasma Trough Concentrations with Patient-, Treatment-, and Disease-Related Factors Among HIV/HCV-Coinfected Persons;European Journal of Drug Metabolism and Pharmacokinetics;2021-10-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3